Development History and Core Business
-
History: Founded in 2005, Bailong has consistently focused on the functional ingredients sector. Through relentless technological innovation and product development, it has gradually built a strong market position in prebiotics, dietary fibers, and healthy sweeteners. The company began its prebiotics line in 2007 with products like Isomaltooligosaccharide and Fructooligosaccharide. It entered the dietary fiber market in 2015, launching Polydextrose and Resistant Dextrin. The expansion into healthy sweeteners followed in 2019 with products like Allulose. By the first half of 2025, Bailong had secured 89 invention patents covering core production technologies for products like Resistant Dextrin and Allulose.
-
Products: Bailong's main product lines include Prebiotics (e.g., FOS, XOS, GOS), Dietary Fibers (e.g., Resistant Dextrin, Polydextrose), Healthy Sweeteners (e.g., Allulose, Isomaltulose), and other starch sugars. Continuous product innovation and technological upgrades enable the company to meet the growing market demand for healthy ingredients.
Industry Landscape
Driven by rising health consciousness, demand for prebiotics, dietary fibers, and healthy sweeteners continues to grow. According to QYResearch, the global prebiotics market is projected to grow at a CAGR of 8.8% from 2023 to 2030, while the dietary fiber market is expected to see a CAGR of 10.03% during the same period. Allulose, as an excellent sucrose alternative, is forecast to achieve a CAGR exceeding 14% from 2025 to 2034. These figures indicate sustained rapid growth for the healthy ingredients market in the coming years.
Supply Chain Analysis
Operating within a healthy ingredients supply chain encompassing raw material procurement, production processing, and sales, Bailong plays a crucial role, particularly in production. Through technological innovation and capacity expansion, it continuously improves product quality and production efficiency. Close collaboration with upstream and downstream partners ensures stable raw material supply, while high-quality products and services earn customer trust.
R&D-Driven Growth and Capacity Expansion
-
R&D Investment: Bailong places high priority on R&D, consistently developing new products and technologies. In 2024, its R&D expenditure reached 44 million RMB, a 36.6% year-on-year increase. With a high-caliber R&D team comprising 10.2% of its technical staff, the company has achieved significant breakthroughs in core products like Allulose and Resistant Dextrin, placing its product metrics at an industry-leading level.
-
Capacity Expansion: To meet market demand, Bailong is actively advancing its capacity expansion plans. A new project producing 30,000 tons of soluble dietary fiber and 15,000 tons of crystalline sugar commenced operation in 2024, significantly boosting production capability. Additionally, a 46,000-ton project in Thailand and a 13,000-ton domestic project are underway, expected to further enhance market competitiveness. This expansion not only addresses current client needs but also lays a solid foundation for future market growth.
-
Product Mix Optimization: By continuously optimizing its product structure and increasing the proportion of high-value products, Bailong has driven overall gross margin improvement. In 2024, the gross margin for its dietary fiber products reached 41.6%, while healthy sweeteners achieved 28.0%. This optimization enhances both profitability and market competitiveness.
Market Outlook and Competitive Edge
-
Market Outlook: As global health awareness rises, demand for prebiotics, dietary fibers, and healthy sweeteners is set for sustained growth, particularly in healthy foods, beverages, and supplements. Leveraging its advantages in technology, R&D, and product quality, Bailong is well-positioned to secure a favorable stance in future market competition. Continuous product innovation and market expansion are expected to support ongoing performance growth.
-
Competitive Advantages: Bailong's core strengths lie in its robust R&D capability and superior product quality. Sustained R&D investment has enabled mastery of multiple core technologies, granting its products strong market competitiveness. Furthermore, a diverse product portfolio and high-quality international certification systems have earned recognition from numerous global clients. Collaboration with major international customers further solidifies its market position.
-
Business Model: Centered on R&D-driven innovation, Bailong's business model focuses on meeting market demand for healthy ingredients through continuous technological advancement and product upgrades. Close cooperation with supply chain partners ensures stable raw material supply and effective product marketing. Excellent customer service and consistent product quality foster customer trust and loyalty. This model not only enhances the company's market competitiveness but also establishes a solid foundation for its future development.
